Projected Uptake of New Antiretroviral (ARV) Medicines in Adults in Low- and Middle-Income Countries: A Forecast Analysis 2015-2025-Reference-Cited by-同舟云学术

Projected Uptake of New Antiretroviral (ARV) Medicines in Adults in Low- and Middle-Income Countries: A Forecast Analysis 2015-2025

Published:2016-10-13 Issue:10 Volume:11 Page:e0164619
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Gupta Aastha,Juneja Sandeep,Vitoria Marco,Habiyambere Vincent,Nguimfack Boniface Dongmo,Doherty Meg,Low-Beer Daniel

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference41 articles.

1. Fact Sheet 2016. Global Statistics 2015,2016

2. How AIDS changed everything—MDG6: 15 years, 15 lessons of hope from the AIDS response,2015

3. FAST-TRACK: Ending the AIDS epidemic by 2030,2014

4. Understanding Fast Track: Accelerating action to end the AIDS epidemic by 2030,2015

5. ViiV Healthcare. Press Release. ViiV Healthcare announces U.S. approval of Tivicay^® (dolutegravir) for the treatment of HIV-1. 12th August 2013. Available: https://www.viivhealthcare.com/media/press-releases/2013/august/viiv-healthcare-announces-us-approval-of-tivicay-dolutegravir-for-the-treatment-of-hiv-1.aspx. Accessed 6 August 2016.

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Underlying Neural Mechanisms of Cognitive Improvement in Fronto-striatal Response Inhibition in People Living with HIV Switching Off Efavirenz: A Randomized Controlled BOLD fMRI Trial;Infectious Diseases and Therapy;2024-04-20

2. Fracture Risk and Association With TDF Use Among People With HIV in Large Integrated Health Systems;JAIDS Journal of Acquired Immune Deficiency Syndromes;2023-12-01

3. Durability of the Efficacy and Safety of Dolutegravir-Based and Low-Dose Efavirenz–Based Regimens for the Initial Treatment of Human Immunodeficiency Virus Type 1 Infection in Cameroon: Week 192 Data of the NAMSAL-ANRS-12313 Study;Open Forum Infectious Diseases;2023-11-20

4. Antiretroviral Regimen and Pregnancy Outcomes of Women Living With Human Immunodeficiency Virus in a US Cohort;Infectious Diseases in Clinical Practice;2023-09-25

5. Voluntary licensing of long‐acting HIV prevention and treatment regimens: using a proven collaboration‐ and competition‐based mechanism to rapidly expand at‐scale, sustainable, quality‐assured and affordable supplies in LMICs;Journal of the International AIDS Society;2023-07